Klaus Maleck currently serves as the Chief Financial Officer at ITM Isotopen Technologien München AG and as an Operating Partner at ArchiMed. Prior to these roles, Klaus was the CEO at Tetec AG and the CFO at Evotec. Klaus attended esbs for their education.
October, 2020 - present